Oberholzer-Gee, Felix. "Amgen Inc.'s Epogen-Commercializing the First Biotech Blockbuster Drug (TN)." Harvard Business School Teaching Note 707-542, March 2007.

Today, Benzinga 's options scanner spotted 28 uncommon options trades for Amgen. This isn't normal. The overall sentiment of ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The patent infringement lawsuit between Amgen (Thousand Oaks, CA) and Transkaryotic Therapies (TKT; Cambridge, MA), to determine which has the US right to exclude others from “making, importing ...